Research
FARE Innovation Series with Nurry Hong
Bringing the best in innovation, science and tech to the food allergy community and beyond
FARE Innovation Series with Nurry Hong
Nurry Hong is a national food allergy advocate and proud father to a child living with food allergies. Nurry is currently Chief Executive Officer and Board Director of Pareto Bio, which is a biopharmaceutical company with a mission to use the human microbiome to treat and prevent chronic immune diseases. Prior to joining Pareto Bio, Nurry served as FARE’s Chief of Strategy and Innovation where he was responsible for helping the organization achieve it’s mission to accelerate food allergy research with the ultimate goal of providing curative therapies to families and children with food allergies.
The History of Anti-IgE Therapy (Xolair®) in Food Allergy with Dr. Dale Umetsu
A World Without Disease: Investing in Prevention and Disease Interception
Current State of the Science in Food Allergy Research